0002024197-24-000001.txt : 20240606 0002024197-24-000001.hdr.sgml : 20240606 20240606155825 ACCESSION NUMBER: 0002024197-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 EFFECTIVENESS DATE: 20240606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nodal Therapeutics, Inc. CENTRAL INDEX KEY: 0002024197 ORGANIZATION NAME: IRS NUMBER: 992312011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515359 FILM NUMBER: 241024895 BUSINESS ADDRESS: STREET 1: 1804 EDGEWATER PARKWAY CITY: SILVER SPRING STATE: MD ZIP: 20903 BUSINESS PHONE: 608-215-5779 MAIL ADDRESS: STREET 1: 1804 EDGEWATER PARKWAY CITY: SILVER SPRING STATE: MD ZIP: 20903 D 1 primary_doc.xml X0708 D LIVE 0002024197 Nodal Therapeutics, Inc. 1804 EDGEWATER PARKWAY SILVER SPRING MD MARYLAND 20903 608-215-5779 DELAWARE None None Corporation true 2024 Christopher Jewell 1804 Edgewater Parkway Silver Spring MD MARYLAND 20903 Executive Officer Director Jonathan S. Bromberg 1804 Edgewater Parkway Silver Spring MD MARYLAND 20903 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2024-05-23 false true true Simple Agreement for Future Equity false 0 100000 100000 0 false 1 0 0 0 false Nodal Therapeutics, Inc. /s/ Christopher Jewell Christopher Jewell Chief Executive Officer 2024-06-06